Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B B Aggarwal

Showing results (211-220 of 220) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 220 results.
Nature|December 20, 1984
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activityP W Gray, B B Aggarwal, C V Benton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunityM A Palladino, M R Shalaby, S M Kramer, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1986
Tumor necrosis factors: gene structure and biological activitiesD V Goeddel, B B Aggarwal, P W Gray, et al.
Molecular Carcinogenesis|November 24, 1999
Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: modulation of migration and invasion of human malignant glioma cellsS K Chintala, A P Kyritsis, P M Mohan, et al.
The Journal of Biological Chemistry|February 25, 1985
Human tumor necrosis factor. Production, purification, and characterizationB B Aggarwal, W J Kohr, P E Hass, et al.
International Journal of Cancer|April 15, 1988
The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studiesJ T Rutka, J R Giblin, M E Berens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytesP M Peters, J R Ortaldo, M R Shalaby, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 10, 1998
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorptionB S Kwon, S Wang, N Udagawa, et al.
Cancer Research|August 1, 1997
Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRGY E Shi, J Ni, G Xiao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 5, 1999
VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivoY Zhai, J Ni, G W Jiang, et al.
Pageof 22

Showing results (211-220 of 220) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 220 results.
Nature|December 20, 1984
Cloning and expression of cDNA for human lymphotoxin, a lymphokine with tumour necrosis activityP W Gray, B B Aggarwal, C V Benton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1987
Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunityM A Palladino, M R Shalaby, S M Kramer, et al.
Cold Spring Harbor Symposia on Quantitative Biology|January 1, 1986
Tumor necrosis factors: gene structure and biological activitiesD V Goeddel, B B Aggarwal, P W Gray, et al.
Molecular Carcinogenesis|November 24, 1999
Altered actin cytoskeleton and inhibition of matrix metalloproteinase expression by vanadate and phenylarsine oxide, inhibitors of phosphotyrosine phosphatases: modulation of migration and invasion of human malignant glioma cellsS K Chintala, A P Kyritsis, P M Mohan, et al.
The Journal of Biological Chemistry|February 25, 1985
Human tumor necrosis factor. Production, purification, and characterizationB B Aggarwal, W J Kohr, P E Hass, et al.
International Journal of Cancer|April 15, 1988
The effects of human recombinant tumor necrosis factor on glioma-derived cell lines: cellular proliferation, cytotoxicity, morphological and radioreceptor studiesJ T Rutka, J R Giblin, M E Berens, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 15, 1986
Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytesP M Peters, J R Ortaldo, M R Shalaby, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 10, 1998
TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorptionB S Kwon, S Wang, N Udagawa, et al.
Cancer Research|August 1, 1997
Antitumor activity of the novel human breast cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRGY E Shi, J Ni, G Xiao, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 5, 1999
VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivoY Zhai, J Ni, G W Jiang, et al.
Pageof 22